Cutaneous manifestations of gastrointestinal disease: Part II

Journal of the American Academy of Dermatology

Volumn 68, Issue 2, 2013, Pages 211.e1-211.e33

  Thrash, Breck ^a   Patel, Mahir ^a   Shah, Kejal R ^a   Boland, C Richard ^a   Menter, Alan ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOSPORIN; DAPSONE; DIPYRIDAMOLE; DOXORUBICIN; ECALIZUMAB; ESTROGEN; ETANERCEPT; FOLIC ACID; INFLIXIMAB; MEPREDNISONE; METHOTREXATE; MONOCLONAL ANTIBODY; MOUTHWASH; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROGESTERONE; PYRIDOXINE; RIBOFLAVIN; SALAZOSULFAPYRIDINE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACRODERMATITIS ENTEROPATHICA; ANAPHYLACTOID PURPURA; APHTHOUS ULCER; ARTICLE; ARTIFICIAL EMBOLISM; BARIATRIC SURGERY; BOWEL ASSOCIATED DERMATOSIS ARTHRITIS SYNDROME; CLINICAL FEATURE; CROHN DISEASE; CUTANEOUS POLYARTERITIS NODOSA; DERMATITIS HERPETIFORMIS; DIVERTICULITIS; EHLERS DANLOS SYNDROME; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA NODOSUM; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPOSI SARCOMA; MALIGNANT ATROPHIC PAPULOSIS; NECROTIZING ARTERITIS; OCULAR ALBINISM; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; PULSED DYE LASER; PUSTULOSIS PALMOPLANTARIS; PYODERMA GANGRENOSUM; PYOSTOMATITIS VEGETANS; RENDU OSLER WEBER DISEASE; RIBOFLAVIN DEFICIENCY; SKIN DISEASE; ULCERATIVE COLITIS;

EID: 84872312449     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.10.036     Document Type: Review

References (271)

1. E.V. Loftus Jr., M.D. Silverstein, W.J. Sandborn, W.J. Tremaine, W.S. Harmsen, and A.R. Zinsmeister Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gut 46 2000 336 343
2. B. Lashner Inflammatory bowel disease W.D. Carey, Cleveland Clinic: current clinical medicine 2009 2009 Saunders Philadelphia
3. R.J. Xavier, and D.K. Podolsky Unraveling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
4. R. Thoreson, and J.J. Cullen Pathophysiology of inflammatory bowel disease: an overview Surg Clin North Am 87 2007 575 585
5. J.C. Barrett, J.C. Lee, C.W. Lees, N.J. Prescott, C.A. Anderson, and A. Phillips Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region Nat Genet 41 2009 1330 1334
6. J.P. Hugot, P. Laurent-Puig, C. Gower-Rousseau, J.M. Olson, J.C. Lee, and L. Beaugerie Mapping of a susceptibility locus for Crohn's disease on chromosome 16 Nature 379 1996 821 823
7. J. Cavanaugh International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn's disease and chromosome 16 Am J Hum Genet 68 2001 1165 1171
8. J.D. Ohmen, H.Y. Yang, K.K. Yamamoto, H.Y. Zhao, Y. Ma, and L.G. Bentley Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis Hum Mol Genet 5 1996 1679 1683
9. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease J Immunol 157 1996 1261 1270
10. A. Ekbom, C. Helmick, M. Zack, and H.O. Adami Ulcerative colitis and colorectal cancer. A population-based study N Engl J Med 323 1990 1228 1233
11. A.S. Paller Cutaneous changes associated with inflammatory bowel disease Pediatr Dermatol 3 1986 439 445
12. S.K. Ward, H.H. Roenigk, and K.B. Gordon Dermatologic manifestations of gastrointestinal disorders Gastroenterol Clin North Am 27 1998 615 636
13. G.B. Rankin, H.D. Watts, C.S. Melnyk, and M.L. Kelley Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications Gastroenterology 77 1979 914 920
14. C.N. Bernstein, J.F. Blanchard, P. Rawsthorne, and N. Yu The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study Am J Gastroenterol 96 2001 1116 1122
15. L. Jiang, B. Xia, J. Li, M. Ye, W. Yan, and C. Deng Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central China Inflamm Bowel Dis 12 2006 212 217
16. L. Lakatos, T. Pandur, G. David, Z. Balogh, P. Kuronya, and A. Tollas Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25 year follow-up study World J Gastroenterol 9 2003 2300 2307
17. T.J. Malins, A. Wilson, and R.P. Ward-Booth Recurrent buccal space abscesses: a complication of Crohn's disease Oral Surg Oral Med Oral Pathol 72 1991 19 21
18. M. Plauth, H. Jenss, and J. Meyle Oral manifestations of Crohn's disease. An analysis of 79 cases J Clin Gastroenterol 13 1991 29 37
19. T. Stricker, and C.P. Braegger Images in clinical medicine. Oral manifestations of Crohn's disease N Engl J Med 342 2000 1644
20. A.J. Williams, D. Wray, and A. Ferguson The clinical entity of orofacial Crohn's disease Q J Med 79 1991 451 458
21. L. Halme, J.H. Meurman, P. Laine, K. von Smitten, S. Syrjänen, and C. Lindqvist Oral findings in patients with active or inactive Crohn's disease Oral Surg Oral Med Oral Pathol 76 1993 175 181
22. A. Dupuy, J. Cosnes, J. Revuz, J.C. Delchier, J.P. Gendre, and A. Cosnes Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases Arch Dermatol 135 1999 439 442
23. M. Lebwohl, R. Fleischmajer, H. Janowitz, D. Present, and P.G. Prioleau Metastatic Crohn's disease J Am Acad Dermatol 10 1984 33 38
24. E.B. Hawryluk, L. Izikson, and J.C. English Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions Am J Clin Dermatol 11 2010 171 181
25. A.G. Cockburn, J. Krolikowski, K. Balogh, and A. Roth Crohn disease of penile and scrotal skin Urology 15 1980 596 598
26. G.D. Guest, and R.L. Fink Metastatic Crohn's disease: case report of an unusual variant and review of the literature Dis Colon Rectum 43 2000 1764 1766
27. D. Farhi, J. Cosnes, N. Zizi, O. Chosidow, P. Seksik, and L. Beaugerie Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients Medicine (Baltimore) 87 2008 281 293
28. A.J. Moraes, P.M. Soares, A.L. Zapata, A.P. Lotito, A.M. Sallum, and C.A. Silva Panniculitis in childhood and adolescence Pediatr Int 48 2006 48 53
29. A.J. Greenstein, H.D. Janowitz, and D.B. Sachar The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients Medicine 55 1976 401 412
30. H.J. Freeman Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease Can J Gastroenterol 10 2005 603 606
31. R.S.W. Basler, and H.V. Dubin Ulcerative colitis and the skin Arch Dermatol 112 1976 531 534
32. L.B. Trost, and J.K. McDonnell Important cutaneous manifestations of inflammatory bowel disease Postgrad Med J 81 2005 580 585
33. F.T. Veloso, J. Carvalho, and F. Magro Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients J Clin Gastroenterol 23 1996 29 34
34. L. Brocq New contribution to the study of geometric phagedaenism [in French] Ann Dermatol Syphil (Paris) 6 1916 1 39
35. F.C. Powell, A.L. Schroeter, W.P.D. Su, and H.O. Perry Pyoderma gangrenosum: a review of 86 patients Q J Med 55 1985 173 186
36. J.H. Prystowsky, S.N. Kahn, and G.S. Lazarus Present status of pyoderma gangrenosum Arch Dermatol 125 1989 57 64
37. F.C. Powell, W.P.D. Su, and H.O. Perry Pyoderma gangrenosum: classification and management J Am Acad Dermatol 34 1996 395 409
38. J.P. Callen Pyoderma gangrenosum Lancet 351 1998 581 585
39. M. Keltz, M. Lebwohl, and S. Bishop Peristomal pyoderma gangrenosum J Am Acad Dermatol 27 1993 360 364
40. A.P. Hughes, J.M. Jackson, and J.P. Callen Clinical features and treatment of peristomal pyoderma gangrenosum JAMA 284 2000 1546 1548
41. J. Reichrath, G. Bens, A. Bonowitz, and W. Tilgen treatment recommendations for pyoderma gangrenosu: an evidence-based review of the literature based on more than 350 patients J Am Acad Dermatol 53 2005 273 283
42. R.K.P. Chow, and V.C. Ho Treatment of pyoderma gangrenosum J Am Acad Dermatol 34 1996 1047 1060
43. E. Ricart, R. Panaccione, E.V. Loftus, W.J. Tremaine, and W.J. Sandborn Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients Am J Gastroenterol 96 2001 722 729
44. P. Juillerat, S. Christen-Zach, F.X. Troillet, S. Gallot-Lavallee, R.G. Pannizzon, and P. Michetti Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis Dermatology 215 2007 245 251
45. T.N. Brooklyn, M.G.S. Dunnill, A. Shetty, J.J. Bowden, J.D.L. Williams, and C.E.M. Griffiths Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial Gut 55 2006 505 509
46. M.A. Fonder, D.L. Cummins, B.D. Ehst, G.J. Anhalt, and J.H. Meyerle Adalimumab therapy for recalcitrant pyoderma gangrenosum J Burns Wounds 5 2006 66 71
47. F. Femiano, A. Lanza, C. Buonaiuto, L. Perillo, A. Dell'Ermo, and N. Cirillo Pyostomatitis vegetans: a review of the literature Med Oral Patol Oral Cir Bucal 14 2009 E114 E117
48. D.D. Damm, and J.E. Fantasia Chronic diffuse yellow eruption. Pyostomatitis vegetans Gen Dent 50 2002 561 564
49. T. Brinkmeier, and P.J. Frosch Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone Acta Derm Venereol 81 2001 134 136
50. A.E. Werchniak, C.A. Storm, R.W. Plunkett, E.H. Beutner, and J.G. Dinulos Treatment of pyostomatitis vegetans with topical tacrolimus J Am Acad Dermatol 52 2005 722 723
51. G. Bens, D. Laharie, M. Beylot-Barry, B. Vergier, I. Noblesse, and C. Beylot Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease Br J Dermatol 149 2003 181 184
52. S.B. Woo, and S.T. Sonis Recurrent aphthous ulcers: a review of diagnosis and treatment J Am Dent Assoc 127 1996 1202 1213
53. P. Borrie Cutaneous polyarteritis nodosa Br J Dermatol 87 1972 87 95
54. G.K. Siberry, B.A. Cohen, and B. Johnson Cutaneous polyarteritis nodosa Arch Dermatol 130 1994 884 889
55. B.P. Khoo, and S.K. Ng Cutaneous polyarteritis nodosa: a case report and literature review Ann Acad Med Singapore 27 1998 868 872
56. A.J. Morgan, and R.A. Schwartz Cutaneous polyarteritis nodosa: a comprehensive review Int J Derm 49 2010 750 756
57. M.S. Daoud, K.P. Jutton, and L.E. Gibson Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases Br J Dermatol 136 1997 706 713
58. G.O. Solley, R.K. Winkelmann, and R.A. Rovelstad Correlation between regional enteritis and cutaneous polyarteritis nodosa: two cases and review of the literature Gastroenterology 69 1975 235 239
59. J.L. Diaz, A.L. Schroeter, and R.K. Winkelmannn Cutaneous periarteritis nodosa: immunofluorescence studies Arch Dermatol 116 1980 56 58
60. S. Akbulu, E. Ozaslan, F. Topal, L. Albayrak, B. Kayhan, and C. Efe Ulcerative colitis presenting as leukocytoclastic vasculitis of skin World J Gastroenterol 14 2008 2448 2450
61. W.M. Sams Jr., E.G. Thorne, P. Small, M.F. Mass, R.M. McIntosh, and R.E. Stanford Leukocytoclastic vasculitis Arch Dermatol 112 1976 219 226
62. J. Zlatanic, M. Fleisher, M. Sasson, P. Kim, and B.I. Korelitz Crohn's disease and acute leukocytoclastic vasculitis of skin Am J Gastroenterol 91 1996 2410 2413
63. F. Iannone, C. Scioscia, A. Musio, D. Piscitelli, and G. Lapadula Leucocytoclastic vasculitis as onset symptom of ulcerative colitis Ann Rheum Dis 62 2003 785 786
64. N. Zitomersky, M. Verhave, and C. Trenor III Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention Inflamm Bowel Dis 17 2011 458 470
65. R.W. Talbot, J. Heppell, R.R. Dozois, and R.W. Beart Jr. Vascular complications of inflammatory bowel disease Mayo Clin Proc 61 1986 140 145
66. C.A. Solem, E.V. Loftus, W.J. Tremaine, and W.J. Sandborn Venous thromboembolism in inflammatory bowel disease Am J Gastroenterol 99 2004 97 101
67. O. Grip, P.J. Svensson, and S. Lindgren Inflammatory bowel disease promotes venous thrombosis earlier in life Scan J Gastroenterol 35 2000 619 623
68. A.T. Cohen, B.L. Davidson, A.S. Gallus, M.R. Lassen, M.H. Prins, and W. Tomkowski Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial BMJ 332 2006 325 329
69. A. Leizorovicz, A.T. Cohen, A.G. Turpie, C.G. Olsson, P.T. Vaitkus, and S.Z. Goldhaber Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
70. M.M. Samama, A.T. Cohen, J.Y. Darmon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 1999 793 800
71. M. Chen, E.A. O'Toole, J. Sanghavi, N. Mahmud, D. Kelleher, and D. Weir The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen J Invest Dermatol 118 2002 1059 1064
72. L.S. Chan, M. Chen, and D.T. Woodley Epidermolysis bullosa acquisita in the elderly J Geriatr Dermatol 4 1996 47 52
73. B.R. Hughes, and J. Horne Epidermolysis bullosa acquisita and total ulcerative colitis J R Soc Med 81 1988 473 475
74. C. Sitaru, S. Mihai, C. Otto, M.T. Chiriac, I. Hausser, and B. Dotterweich Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen J Clin Invest 115 2005 870 878
75. D.T. Woodley, R. Ram, A. Doostan, P. Bandyopadhyay, Y. Huang, and J. Remington Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients J Invest Dermatol 126 2006 1323 1330
76. L. Chen, J.D. Peterson, W.Y. Zheng, S.X. Lin, and L.S. Chan Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells Clin Exp Immunol 145 2006 322 331
77. M. Chen, M.P. Marinkovich, J.C. Jones, E.A. O'Toole, Y.Y. Li, and D.T. Woodley NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats J Invest Dermatol 112 1999 177 183
78. H.H. Roenigk, J.G. Ryan, and W.F. Bergfeld Epidermolysis bullosa acquisita: report of three cases and review of all published cases Arch Dermatol 103 1971 1 10
79. S. Klein, L. Mayer, D.H. Present, K.D. Youner, M.A. Cerulli, and D.B. Sachar Extraintestinal manifestations in patients with diverticulitis Ann Intern Med 108 1988 700 702
80. D. Kurgansky, and M.M. Foxwell Jr. Pyoderma gangrenosum as a cutaneous manifestation of diverticular disease South Med J 86 1993 581 584
81. S. Ahmadi, and F.C. Powell Pyoderma gangrenosum: uncommon presentations Clin Dermatol 23 2005 612 620
82. A.J. Kremen, J.H. Linner, and C.H. Nelson An experimental evaluation of the nutritional importance of proximal and distal small intestine Ann Surg 140 1954 439 448
83. W.O. Griffen Jr., B.A. Bivins, and R.M. Bell The decline and fall of jejunoileal bypass Surg Gynecol Obstet 157 1983 301 308
84. J.R. Person, and J.D. Bernhard Autointoxication revisited J Am Acad Dermatol 15 1986 559 563
85. C.H. Dicken, and J.R. Seehafer Bowel bypass syndrome Arch Dermatol 115 1979 837 839
86. J.L. Jorizzo, P. Apisarnthanarax, P. Subrt, A.A. Hebert, J.C. Henry, and S.S. Raimer Bowel-bypass syndrome without bowel bypass. Bowel-Associated dermatosis-Arthritis syndrome Arch Intern Med 143 1983 457 461
87. C. Fisch, P. Schiller, T. Harr, and D. Maclachlan First presentation of intestinal bypass syndrome 18yr after initial surgery Rheumatology 40 2001 351 353
88. J.L. Jorizzo Pustular vasculitis: an emerging disease concept J Am Acad Dermatol 9 1983 160 162
89. P.H. Ely The bowel bypass syndrome: a response to bacterial peptidoglycans J Am Acad Dermatol 15 1980 559 563
90. C.H. Dicken Bowel-Associated dermatosis-Arthritis syndrome: bowel bypass syndrome without bowel bypass J Am Acad Dermatol 14 1986 792 796
91. P.H. Ely, and P.D. Utsinger Clinical observations and immunologic abnormalities following bowel bypass surgery J Am Acad Dermatol 2 1980 529 530
92. S.E. Presser, H. Blank, and V.A. Ziboh Essential fatty acid deficiency after intestinal bypass J Am Acad Dermatol 8 1983 127 128
93. S. Gómez-Diez, V.A. Mas, T. Soler, F. Vázquez-López, and O.N. Pérez Vitamin A deficiency and bowel-Associated dermatosis-Arthritis syndrome secondary to biliopancreatic diversion for obesity Actas Dermosifiliogr 101 2010 900 902
94. G.H. Slater, P. Kerlin, P.R. Georghiou, and G.A. Fielding Bowel-Associated dermatosis-Arthritis syndrome after biliopancreatic diversion Obes Surg 14 2004 133 135
95. J. Tu, J.J. Chan, and L.L. Yu Bowel bypass syndrome/bowel-Associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery Australas J Dermatol 52 2011 e5 e7
96. L. Prpic-Massari, M. Kastelan, I. Brajac, L. Cabrijan, G. Zamolo, and D. Massari Bowel-Associated dermatosis-Arthritis syndrome in a patient with appendicitis Med Sci Monit 13 2007 97 100
97. D. Ashok, and P. Kiely Bowel associated dermatosis-Arthritis syndrome: a case report J Med Case Rep 1 2007 81
98. A.R. Guerre-Schmidt, F. Pelletier, F. Carbonnel, P. Humbert, and F. Aubin Dermatosis-Arthritis syndrome associated with Crohn's disease in a teenager [in French] Rev Med Interne 27 2006 874 877
99. R. Rapini Practical dermatopathology 2005 Elsevier Philadelphia pp. 67-9
100. W. Heberden Commentarii di morborium historia et curatione. London: Payne; 1801. Reprinted as Commentaries on the history and cure of diseases 1982 The Classics of Medicine Library, Division of Gryphon Editions, Ltd Birmingham (AL) pp. 395-7
101. E.H. Henoch Uber eine eigenthumliche Form von Purpura Berl Klin Wochenschr 11 1874 641 643
102. E.H. Henoch Vorlesungen uber Kinderkrankheiten A. Hirschward, Vohlesunger uber Kinderkrankheiten 1899 Aufl Berlin 839
103. F.T. Saulsbury Henoch-Schönlein purpura in children: report of 100 patients and review of the literature Medicine 78 1999 395 409
104. Y.K. Abdel-Ao, Z. Hejazi, and H.A. Majeed Henoch-Schonlein purpura in Arab children. Analysis of 52 cases Trop Geogr Med 42 1990 52 57
105. D.M. Allen, L.K. Diamond, and D.A. Howell Anaphylactoid purpura in children (Shonlein-Henoch syndrome) Am J Dis Child 99 1960 833 854
106. M. Al-Sheyyab, H. El-Shanti, S. Ajlouni, A. Batieha, and A.S. Daoud Henoch-Schonlein purpura: clinical experience and contemplations on a streptococcal association J Trop Pediatr 42 1996 200 203
107. N. Bilaloglu Shonlein-Henoch syndrome Clin Pediatr 2 1963 541 544
108. H.E. Nielsen Epidemiology of Schonlein-Henoch purpura Acta Paediatr Scand 77 1988 125 131
109. W.L.M. Robson, and A.K.C. Leung Henoch-Schonlein purpura Adv Pediatr 41 1994 163 194
110. F.T. Saulsbury Henoch-Schonlein purpura Curr Opin Rheumatol 22 2010 598 602
111. Y.H. Yang, Y.H. Chuang, L.C. Wang, H.Y. Huang, M.E. Gershwin, and B.L. Chiang The immunobiology of Henoch-Schonlein purpura Autoimmun Rev 7 2008 179 184
112. F.T. Saulsbury Alterations in the O-linked glycosylation of the IgA1 in children with henoch-Schonlein purpura J Rheumatol 24 1997 2246 2249
113. A.C. Allen, F.R. Willis, T.J. Beattie, and J. Feehally Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis Nephrol Dial Translplant 13 1998 930 934
114. J.A. Mills, B.A. Michel, D.A. Bloch, L.H. Calabrese, G.G. Hunder, and W.P. Arend The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura Arthritis Rheum 33 1990 1114 1121
115. J.J. Cream, J.M. Gumpel, and R.D.G. Peachey Schonlein-Henoch purpura in the adult Q J Med 39 1970 461 484
116. E. Tancrede-Gohin, S. Ochonisky, M.D. Vignon-Pennamen, B. Flageul, P. Morel, and M. Rybojad Schonlein-Henoch purpura in adult patients Arch Dermatol 133 1997 438 442
117. D. Gairdner The Schonlein-Henoch syndrome (anaphylactoid purpura) Q J Med 17 1948 95 122
118. R.L. Vernier, H.G. Wosrthen, R.D. Peterson, E. Colle, and R.A. Good Anaphylactoid purpura. Pathology of the skin and kidney and frequency of streptococcal infection Pediatrics 27 1961 181 193
119. J. Giangiacomo, and C.C. Tsai Dermal and glomerular deposition of IgA in anaphylactoid purpura Am J Dis Child 131 1977 981 983
120. J.A. Stevenson, L.A. Leong, A.H. Cohen, and W.A. Border Henoch-Schonlein purpura. Simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney Arch Pathol Lab Ed 106 1982 192 195
121. M. Stewart, J.M. Savage, B. Bell, and B. McCord Long-term renal prognosis of henoch-Schonlein purpura in an unselected childhood population Eur J Pediatr 147 1988 113 115
122. M. Sussman, J.H. Jones, J.D. Almelda, and P.J. Lachmann Deficiency of the second component of complement associated with anaphylactoid purpura and the presence of mycoplasma in the serum Clin Exp Immunol 14 1973 531 539
123. M.F. Fredenberg, and F.D. Malkinson Slufone therapy in the treatment of leukocytoclastic vasculitis J Am Acad Dermatol 16 1987 772 778
124. B.I. Hoffbrand Dapsone in Henoch-Schonlein purpura-worth a trial? Postgrad Med J 67 1991 961 962
125. J.A. Ledermann, and B.I. Hoffbrand Dapsone in allergic vasculitis: its use in Henoch-Schonlein disease following vaccination J R Soc Med 76 1983 613 614
126. I.S. Szer Henoch-Schonlein purpura: when and how to treat J Rheumatol 23 1996 1661 1665
127. O. Koskimies, S. Mir, J. Rapola, and J. Vilska Henoch-Schonlein nephritis: long-term prognosis of unselected patients Arch Dis Child 56 1981 482 484
128. M. Levy, M. Broyer, A. Arsan, D. Levy-Bentolila, and R. Habib Anaphylactoid purpura nephritis in childhood: natural history and immunopathology Adv Nephrol 6 1976 183 228
129. S.R. Meado, E.F. Glasgow, R.H.R. White, M.W. Moncrieff, J.S. Cameron, and C.S. Ogg Schonlein-Henoch nephritis Q J Med 41 1972 241 258
130. J. Ronkainen, O. Koskimies, M. Ala-Houhala, M. Antikainen, J. Merenmies, and J. Rajantie Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial J Pediatr 149 2006 241 247
131. J. Dudley, G. Smith, A. Llewellyn-Edwards, and E. Tizard Randomised placebo controlled trial to assess the role of early prednisone on the development and progression of Henoch-Schonlein purpura nephritis Pediatr Nephrol 22 2007 1457
132. A.M. Huber, J. King, P. McLaine, T. Klassen, and M. Pothos A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383] BMC Med 2 2004 7
133. W. Chartapisak, S. Opastiraku, N.S. Willis, J.C. Craig, and E.M. Hodson Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review Arch Dis Child 94 2009 132 137
134. M. Zaffanello, and V. Fanos Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood Pediatr Nephrol 24 2009 1901 1911
135. R. Bogdanovic Henoch-Schonlein purpura nephritis in children: risk factors, prevention and treatment Acta Paediatr 98 2009 1882 1889
136. L. Duhring Dermatitis herpetiformis JAMA 3 1884 225
137. M. Caproni, E. Antiga, L. Melani, and P. Fabbri Italian Group for Cutaneous Immunopathology. Guidelines for the diagnosis and treatment of dermatitis herpetiformis J Eur Acad Dermatol Venereol 23 2009 633 638
138. P. Collin, and T. Reunala Recognition and management of the cutaneous manifestations of celiac disease Am J Clin Dematol 4 2003 13 20
139. J.J. Zone Skin manifestations of celiac disease Gastroenterology 128 2005 S87 S89
140. E. Marietta, K. Black, M. Camilleri, P. Krause, R.S. Rogers 3rd, and C. David A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice J Clin Invest 114 2004 1090 1097
141. M. Sardy, S. Karpati, B. Merkl, and M. Paulsson Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis J Exp Med 195 2002 747 757
142. W. Dieterich, T. Ehnis, M. Bauer, P. Donner, U. Volta, and E.O. Riecken Identification of tissue transglutaminase as the autoantigen of celiac disease Nat Med 3 1997 797 801
143. L. Fry Dermatitis herpetiformis: problems, progress and prospects Eur J Dermatol 12 2002 523 531
144. M.F. Kagnoff AGA Institute Medical position statement on the diagnosis and treatment of celiac disease Gastroenterology 131 2006 1977 1980
145. W.M. Porter, D.J. Unsworth, R.J. Lock, C.M. Hardman, B.S. Baker, and L. Fry Tissue transglutaminase antibodies in dermatitis herpetiformis Gastorenterology 117 1999 749 750
146. W. Dieterich, E. Laag, L. Bruckner-Tuderman, T. Reunala, S. Kárpáti, and T. Zágoni Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis J Invest Dermatol 113 1999 133 136
147. I. Koop, R. Ilchmann, L. Izzi, A. Adragna, H. Koop, and H. Barthelmes Detection of autoantibodies against tissue tranglutaminase in patients with celiac disese and ermatitis herpetiformis Am J Gastorenterol 95 2000 2009 2014
148. M. Caproni, C. Cardinali, D. Renzi, A. Calabrò, and P. Fabbri Tissue tranglutaminase antibody assessment in dermatitis herpetiformis Br J Dermatol 144 2001 196 197
149. V. Kumar, M. Jarzabek-Chorzelska, J. Sulej, M. Rajadhyaksha, and S. Jablonska Tissue transgutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis Clin Immunol 98 2001 378 382
150. M.K. Kosann Dermatitis herpetiformis Dermatol Online J 9 2001 8
151. T. Reunala, I. Kosnai, S. Karpati, P. Kuitunen, E. Török, and E. Savilahti Dermatitis herpetiformis: jejunal findings and skin response to gluten-free diet Arch Dis Child 59 1984 517 522
152. M.M. Maki, and P. Collin Coeliac disease Lancet 349 1997 1755 1759
153. K. Hervonen, M. Hakanen, K. Kaukinen, P. Collin, and T. Reunala First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis Scand J Gastroenterol 37 2002 51 55
154. I. Turchin, and B. Barankin Dermatitis herpetiformis and gluten-free diet Dermatol Online J 11 2005 6
155. C.M. Hardman, J.J. Garioch, and J.N. Leonard Absence of toxicity of oats in patients with dermatitis herpetiformis N Engl J Med 337 1997 1884 1887
156. B.K. Janatuinen, S.A. Pikkarainen, and T.A. Kemppainen A comparison of diets with and without oats in adults with celiac disease N Engl J Med 333 1995 1033 1037
157. J.J. Garioch, H.M. Lewis, S.A. Sargent, J.N. Leonard, and L. Fry 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis Br J Dermatol 131 1994 541 545
158. H.M. Lewis, T.L. Renaula, J.J. Garioch, J.N. Leonard, J.S. Fry, and P. Collin Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis Br J Dermatol 135 1996 363 367
159. O. Sener, L. Doganci, M. Safali, B. Besirbellioglu, F. Bulucu, and A. Pahsa Severe dapsone hypersensitivity syndrome J Investig Allergol Clin Immunol 16 2006 268 270
160. D.F. Talarico, and D.G. Metro Presentation of dapsone-induced methemoglobinemia in a patient status post-bowel transplant J Clin Anesthesia 17 2005 568 570
161. I. Lee, T.D. Barton, S. Goral, A.M. Doyle, R.D. Bloom, and D. Chojnowski Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients Am J Transplant 5 2005 2791 2795
162. S. Damodar, A. Viswabandya, B. George, V. Mathews, M. Chandy, and A. Srivastava Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults - a report of 90 patients Eur J Hematol 75 2005 328 331
163. E.N. Alves-Rodrigues, L.C. Ribeiro, M.D. Silva, A. Takiuchi, and C.J. Fontes Dapsone syndrome with acute renal failure during leprosy treatment: case report Braz J Infect Dis 9 2005 84 86
164. K. Chalioulias, E. Mayer, A. Darvay, and R. Antcliff Anterior ischaemic optic neuropathy associated with dapsone Eye 20 2006 943 945
165. L. Mery, H. Dega, C. Prost, and L. Dubertret Dapsone-induced sensory peripheral neuropathy Ann Dermatol Venereol 130 2003 447 449
166. J.P. McFadden, J.N. Leonard, A.V. Powles, A.J. Rutman, and L. Fry Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid Br J Dermatol 121 1989 759 762
167. E. Willsteed, M. Lee, L.C. Wong, and A. Cooper Sulfasalazine and dermatitis herpetiformis Australas J Dermatol 46 2005 101 103
168. W.K. Woo, S.A. McMillan, R.G. Watson, W.G. McCluggage, J.M. Sloan, and J.C. McMillan Coeliac disease-Associated antibodies correlate with psoriasis activity Br J Dermatol 151 2004 891 894
169. C.L. Chang, M.K. Jones, and J.G. Kingham Celiac disease and autoimmune thyroid disease Clin Med Res 5 2007 184 192
170. H.J. Freeman Pancreatic endocrine and exocrine changes in celiac disease World J Gastroenterol 13 2007 6344 6346
171. J. Alonso-Llamazares, L.E. Gibson, and R.S. Rogers III Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience Int J Dermatol 46 2007 910 919
172. N.R. Lewis, R.F. Logan, R.B. Hubbard, and J. West No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study Aliment Pharmacol Ther 27 2008 1140 1147
173. P. Collin, E. Pukkala, and T. Reunala Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease Gut 38 1996 528 530
174. M. Viljamaa, K. Kaukinen, E. Pukkala, K. Hervonen, T. Reunala, and P. Collin Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study Dig Liver Dis 38 2006 374 380
175. J.N. Leonard, W.F. Tucker, J.S. Fry, C.A. Coulter, A.W. Boylston, and R.M. McMinn Increased incidence of malignancy in dermatitis herpetiformis Br Med J 286 1983 16 18
176. D.J. Gawkrodger, J.N. Blackwell, H.M. Gilmour, E.A. Rifkind, R.C. Heading, and R.S. Barnetson Dermatitis herpetiformis: diagnosis, diet and demography Gut 25 1984 151 157
177. B. Sigurgeirsson, B. Agnarsson, and B. Lindelof Risk of lymphoma in patients with dermatitis herpetiformis Br Med J 308 1994 13 15
178. H.M. Lewis, T.L. Renaula, J.J. Garioch, J.N. Leonard, J.S. Fry, and P. Collin Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis Br J Dermatol 1335 1996 363 367
179. J. Askling, M. Linet, G. Gridley, T.S. Halstensen, K. Ekström, and A. Ekbom Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis Gastroenterology 123 2002 1428 1435
180. W. Kohlmeier Multiple Hautnelnosen bei Thromboangiiits obliterans [in German] Arch Dermatol Syphilol 181 1941 783 784
181. R. Degos Malignant atrophic papulosis Br J Dermatol 100 1979 21 35
182. N. Scheinfeld Malignant atrophic papulosis Clin Exp Dermatol 32 2007 483 487
183. P.R. Mydlarski, D.F. Barber, and L.H. Robertson Painless pink papules with central porcelain-white scars CMAJ 179 2008 1171 1173
184. E.R. Fernández-Pérez, E. Grabscheid, and N.S. Scheinfeld A case of systemic malignant atrophic papulosis (Köhlmeier-Degos' disease) J Natl Med Assoc 97 2005 421 425
185. N. Scheinfeld Commentary on 'Degos disease: a C5b-9/interferon-α- mediated endotheliopathy syndrome' by Magro et al: a reconsideration of Degos disease as hematologic or endothelial genetic disease Dermatol Online J 17 2011 6
186. J. Wilson, H. Walling, and M. Seabury Stone Benign cutaneous Degos disease in a 16-year-oldgirl Ped Dermatol 24 2007 18 24
187. W.A. High, J. Aranda, S.B. Patel, C.J. Cockerell, and M.I. Costner Is Degos' disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol 50 2004 895 899
188. Y. Erzin, S. Cosgun, A. Dobrucali, M. Tasyurekli, S. Erdamar, and M. Tuncer Complicated granulomatous colitis in a patient with Hermansky-Pudlak syndrome, successfully treated with infliximab Acta Gastroenterol Belg 69 2006 213 216
189. T.G. Olsen, S.K. Milroy, L. Goldman, and J.P. Fidler Laser surgery for blue rubber bleb nevus Arch Dermatol 115 1979 81 82
190. A.F. Browne, S. Katz, J. Miser, and E.T. Boles Jr. Blue rubber bleb nevi as a cause of intussusception J Pediatr Surg 18 1983 7 9
191. D. Gonzalez, B.J. Elizondo, S. Haslag, G. Buchanan, J.S. Burdick, and P.C. Guzzetta Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome J Pediatr Gastroenterol Nutr 33 2001 183 188
192. L. Morris, P.M. Lynch, W.A. Gleason Jr., C. Schauder, D. Pinkel, and M. Duvic Blue rubber bleb nevus syndrome: laser photocoagulation of colonic hemangiomas in a child with microcytic anemia Pediatr Dermatol 9 1992 91 94
193. W.T. Ng, and C.K. Kong Argon plasma coagulation for blue rubber bleb nevus syndrome in a female infant Eur J Pediatr Surg 13 2003 137 139
194. E.K. Ng, F.K. Cheung, and P.W. Chiu Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator Dig Endosc 21 2009 40 42
195. S.J. Fishman, C.J. Smithers, J. Folkman, D.P. Lund, P.E. Burrows, and J.B. Mulliken Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding Ann Surg 241 2005 523 528
196. R.P. Finger, P. Charbel Issa, M.S. Ladewig, C. Götting, C. Szliska, and H.P. Scholl Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches Surv Ophthalmol 54 2009 272 285
197. M. Rendu Epistaxis repetees chez un sujet porteur de petits angiomes cutanes et muquex Bull Mem Soc Med Hosp Paris 13 1896 731
198. W. Osler On a family form of recurring epistaxis associated with multiple telangiectases of the skin and mucous membranes Bull Johns Hopkins Hosp 12 1901 333 337
199. F.P. Weber Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages Lancet ii 1907 160 162
200. M.P. Goldman Optimal management of facial telangiectasia Am J Clin Dermatol 5 2004 423 434
201. R.J. Harvey, J. Kanagalingam, and V.J. Lund The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis Am J Rhinol 22 2008 182 187
202. R.K. Shah, J.K. Dhingra, and S.M. Shapshay Hereditary hemorrhagic telangiectasia: a review of 76 cases Laryngoscope 112 2002 767 773
203. E.E. Rebeiz, D.J. Bryan, R.J. Ehrlichman, and S.M. Shapshay Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease Ann Plast Surg 35 1995 208 213
204. E. van Cutsem, P. Rutgeerts, and G. Vantrappen Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone Lancet 335 1990 953 955
205. D.D. Proctor, K.J. Henderson, J.D. Dziura, A.V. Longacre, and R.I. White Jr. Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia J Clin Gastroenterol 39 2005 115 119
206. H.I. Saba, G.A. Morelli, and L.A. Logrono Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid N Engl J Med 330 1994 1789 1790
207. S.R. Checketts, P.S. Burton, D.J. Bjorkman, and D.P. Kadunce Generalized essential telangiectasia in the presence of gastrointestinal bleeding J Am Acad Dermatol 37 2 pt 2 1997 321 325
208. S. Dupuis-Girod, S. Bailly, and H. Plauchu Hereditary hemorrhagic telangiectasia: from molecular biology to patient care J Thromb Haemost 8 2010 1447 1456
209. K.A. McAllister, K.M. Grogg, D.W. Johnson, C.J. Gallione, M.A. Baldwin, and C.E. Jackson Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8 1994 345 351
210. D.W. Johnson, J.N. Berg, M.A. Baldwin, C.J. Gallione, I. Marondel, and S.J. Yoon Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Nat Genet 13 1996 189 195
211. C.L. Shovlin, and M. Letarte Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms Thorax 54 1999 714 729
212. P. Bayrak-Toydemir, J. McDonald, B. Markewitz, S. Lewin, F. Miller, and L.S. Chou Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations Am J Med Genet A 140 2006 463 470
213. W. Romer, M. Burk, and W. Schneider Hereditary hemorrhagic telangiectasia (Osler's disease) [in German] Dtsch Med Wochenschr 117 1992 669 675
214. H. Plauchu, J.P. de Chadarévian, A. Bideau, and J.M. Robert Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population Am J Med Genet 32 1989 291 297
215. P. Vase, and O. Grove Gastrointestinal lesions in hereditary hemorrhagic telangiectasia Gastroenterology 91 1986 1079 1083
216. G.G. Gascoyen Case of naevus involving the parotid gland and causing death from suffocation: naevi of the viscera Trans Pathol Soc (Lond) 11 1860 267
217. W.B. Bean Blue rubber bleb nevi of the skin and gastrointestinal tract. Vascular Spiders and Related Lesions of the Skin 1958 Charles C. Thomas Springfield (IL) pp. 178-85
218. M. Munkvad Blue rubber bleb nevus syndrome Dermatologica 167 1983 307 309
219. D. Ertem, Y. Acar, E. Kotiloglu, D. Yucelten, and E. Pehlivanoglu Blue rubber bleb nevus syndrome Pediatrics 107 2001 418 420
220. B.C. Oksüzoglu, G. Oksüzoglu, U. Cakir, T. Bayir, and M. Esen Blue rubber bleb nevus syndrome Am J Gastroenterol 91 1996 780 782
221. C.O. Park, J. Park, and K.Y. Chung Blue rubber bleb nevus syndrome with central nervous system involvement J Dermatol 33 2006 649 651
222. A.B. Fleischer Jr., S.M. Panzer, and C.E. Wheeler Blue rubber bleb nevus syndrome in a black patient: a case report Cutis 45 1990 103 105
223. J. Shannon, and J. Auld Blue rubber bleb naevus syndrome associated with cortical blindness Australas J Dermatol 46 2005 192 195
224. B.M. Starr, W.K. Katzenmeyer, F. Guinto, and A.M. Pou The blue rubber bleb nevus syndrome: a case with prominent head and neck findings Am J Otolaryngol 26 2005 282 284
225. J.C. McCarthy, M.J. Goldberg, and S. Zimbler Orthopaedic dysfunction in the blue rubber-bleb nevus syndrome J Bone Joint Surg Am 64 1982 280 283
226. P.D. Garen, and E.E. Sahn Spinal cord compression in blue rubber bleb nevus syndrome Arch Dermatol 130 1994 934 935
227. C. Giordano, A. Battagliese, C.R. di Gioia, D. Campagna, F. Benedetti, and C. Travaglini Blue rubber bleb nevus syndrome and pulmonary hypertension: an unusual association Cardiovasc Pathol 13 2004 317 322
228. A.P. Oranje Blue rubber bleb nevus syndrome Pediatr Dermatol 3 1986 304 310
229. S. Mejia-Rodriguez, A. Valencia-Herrera, A. Escobar-Sanchez, and C. Mena-Cedillos Dermoscopic features in Bean (blue rubber bleb nevus) syndrome Pediatr Dermatol 25 2008 270 272
230. D. Dobru, N. Seuchea, M. Dorin, and V. Careianu Blue rubber bleb nevus syndrome: A case report and a literature review Rom J Gastroenterol 13 2004 237 240
231. L.A. Parapia, and C. Jackson Ehlers-Danlos syndrome - a historical review Br J Haematol 141 2008 32 35
232. F. Malfait, R.J. Wenstrup, and A. De Paepe Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type Genet Med 12 2010 597 605
233. D.P. Germain Ehlers-Danlos syndrome type IV Orphanet J Rare Dis 2 2007 32
234. R. Sadakata, A. Hatamochi, K. Kodama, A. Kaga, T. Yamaguchi, and T. Soma Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene Intern Med 49 2010 1797 1800
235. N.L. Sharma, V.K. Mahajan, N. Gupta, N. Ranjan, and A. Lath Ehlers-Danlos syndrome - vascular type (ecchymotic variant): cutaneous and dermatopathologic features J Cutan Pathol 36 2009 486 492
236. Y.K. Hong, K. Foreman, J.W. Shin, S. Hirakawa, C.L. Curry, and D.R. Sage Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-Associated herpesvirus Nat Genet 36 2004 683 685
237. H.J. Kahn, D. Bailey, and A. Marks Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas Mod Pathol 15 2002 434 440
238. E. Kaiserling Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology [in German] Pathologe 25 2004 362 374
239. H. Xu, J.R. Edwards, O. Espinosa, S. Banerji, D.G. Jackson, and N.A. Athanasou Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors Hum Pathol 35 2004 857 861
240. S. Rossi, E. Orvieto, A. Furlanetto, L. Laurino, V. Ninfo, and A.P. Dei Tos Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody Mod Pathol 17 2004 547 552
241. R. Sarid, S.J. Olsen, and P.S. Moore Kaposi's sarcoma-Associated herpesvirus: epidemiology, virology, and molecular biology Adv Virus Res 52 1999 139 232
242. K. Antman, and Y. Chang Kaposi's sarcoma N Engl J Med 342 2000 1027 1038
243. L.P. Jacobson, F.J. Jenkins, G. Springer, A. Muñoz, K.V. Shah, and J. Phair Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma J Infect Dis 181 2000 1940 1949
244. S. Franceschi, and M. Geddes Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population Tumori 81 1995 308 314
245. R. Duprez, V. Lacoste, J. Brière, P. Couppié, C. Frances, and D. Sainte-Marie Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma J Natl Cancer Inst 99 2007 1086 1094
246. T.B. Fitzpatrick, R.A. Johnson, K. Wolff, and D. Suurmond Cutaneous lymphoma and sarcoma Color atlas and synopsis of clinical dermatology 2001 McGraw-Hill Medical Publishing Division New York 525 531
247. I.G. Barrison, S. Foster, J.W. Harris, A.J. Pinching, and J.G. Walker Upper gastrointestinal Kaposi's sarcoma in patients positive for HIV antibody without cutaneous disease Br Med J (Clin Res Ed) 296 1988 92 93
248. S.L. Friedman, T.L. Wright, and D.F. Altman Gastrointestinal Kaposi sarcoma in patients with acquired immunodeficiency syndrome: endoscopy and autopsy findings Gastroenterology 89 1985 102
249. L.A. Guarda, M.A. Luna, J.L. Smith Jr., P.W. Mansell, F. Gyorkey, and A.N. Roca Acquired immunodeficiency syndrome: postmortem findings Am J Clin Pathol 81 1986 549 557
250. G.W. Niedt, and R.A. Schinella Acquired immunodeficiency syndrome: clinic-pathological study of 56 autopsies Arch Pathol Lab Med 109 1985 727 734
251. S. Stewart, H. Jablonowski, F.D. Goebel, K. Arasteh, M. Spittle, and A. Rios Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group J Clin Oncol 16 1998 683 691
252. D.W. Northfelt, B.J. Dezube, J.A. Thommes, B.J. Miller, M.A. Fischl, and A. Friedman-Kien Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial J Clin Oncol 16 1998 2445 2451
253. D. Belotti, V. Vergani, T. Drudis, P. Borsotti, M.R. Pitelli, and G. Viale The microtubule-Affecting drug paclitaxel has antiangiogenic activity Clin Cancer Res 2 1996 1843 1849
254. M.W. Saville, J. Lietzau, J.M. Pluda, I. Feuerstein, J. Odom, and W.H. Wilson Treatment of HIV-Associated Kaposi's sarcoma with paclitaxel Lancet 346 1995 26 28
255. P.S. Gill, A. Tulpule, B.M. Espina, S. Cabriales, J. Bresnahan, and M. Ilaw Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma J Clin Oncol 17 1999 1876 1883
256. L. Welles, M.W. Saville, J. Lietzau, J.M. Pluda, K.M. Wyvill, and I. Feuerstein Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-Associated Kaposi's sarcoma J Clin Oncol 16 1998 1112 1121
257. J.E. Groopman, M.S. Gottlieb, J. Goodman, R.T. Mitsuyasu, M.A. Conant, and H. Prince Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome Ann Intern Med 100 1984 671 676
258. D.I. Abrams, and P.A. Volberding Alpha interferon therapy of AIDS-Associated Kaposi's sarcoma Semin Oncol 13 suppl 2 1986 43 47
259. R. de Wit, S.A. Danner, P.J. Bakker, J.M. Lange, J.K. Eeftinck Schattenkerk, and C.H. Veenhof Combined zidovudine and interferon-Alpha treatment in patients with AIDS-Associated Kaposi's sarcoma J Intern Med 229 1991 35 40
260. I. Penn Kaposi's sarcoma in organ transplant recipients: report of 20 cases Transplantation 27 1979 8 11
261. M. Jen, and A.C. Yan Syndromes associated with nutritional deficiency and excess Clin Dermatol 28 2010 669 685
262. P. Kumar, N.R. Lal, A.K. Mondal, A. Mondal, R.C. Gharami, and A. Maiti Zinc and skin: a brief summary Dermatol Online J 18 2012 1
263. E. Maverakis, M.A. Fung, P.J. Lynch, M. Draznin, D.J. Michael, and B. Ruben Acrodermatitis enteropathica and an overview of zinc metabolism J Am Acad Dermatol 56 2007 116 124
264. N. Danbolt, and K. Closs Acrodermatitis enteropathica Acta Derm Venereol 23 1942 127
265. S. Schmitt, S. Küry, M. Giraud, B. Dréno, M. Kharfi, and S. Bézieau An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica Hum Mutat 30 2009 926 933
266. S. Antala, and R.E. Dempski The human ZIP4 transporter has two distinct binding affinities and mediates transport of multiple transition metals Biochemistry 51 2012 963 973
267. S. Kury, B. Dreno, S. Bezieau, S. Giraudet, M. Kharfi, and R. Kamoun Identification of SLC39A4, a gene involved in acrodermatitis enteropathica Nat Genet 31 2002 239 240
268. R.J. Cousins Metal elements and gene expression Annu Rev Nutr 14 1994 449 469
269. P.E. Johnson, C.D. Hunt, D.B. Milne, and L.K. Mullen Homeostatic control of zinc metabolism in men: zinc excretion and balance in men fed diets low in zinc Am J Clin Nutr 57 1993 557 565
270. J.C. King, K.M. Hambidge, J.L. Westcott, D.L. Kern, and G. Marshall Daily variation in plasma zinc concentrations in women fed meals at six-hour intervals J Nutr 124 1994 508 516
271. H.Y. Paik, H. Joung, J.Y. Lee, H.K. Lee, J.C. King, and C.L. Keen Serum extracellular superoxide dismutase activity as an indicator of zinc status in humans Biol Trace Elem Res 69 1999 45 57